The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...

Some European firms are sacrificing efficiency and losing their global edge as they wall off their operations in China and ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

Lakeside Holding (LSH) announced that its recent acquisition in China, Hupan Pharmaceutical, has entered into a strategic distribution ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

It specifies that by 2035, China expects to fully ensure the safety, efficacy and accessibility of drugs and medical devices, ...

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application ...

The firm also announced that it was divesting most of its equity interest in Shanghai Hutchison Pharmaceuticals to invest in its own pipeline.

Chinese regulators have accepted HUTCHMED's (HCM) application for priority review for the drug combination Orpathys and ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Except for the last nine countries listed in the table—Bulgaria, Romania, Croatia, Montenegro, North Macedonia, Malta, Estonia, Latvia, and Japan—the other 29 countries currently enjoy a 15-day ...

Explore the rankings here. The manufacturing industry is a cornerstone of China’s economy and a crucial sector underpinning the global economy. In 2023, the manufacturing sector’s added value ...